4.First-line chemotherapy alone For patients who have relative contraindications to upfront immunotherapy or PS worse than 1, a histology-appropriate platinum- doublet chemotherapy may be used (see above), with or without bevacizumab added for those with non-squamous histology.
仅一线化疗 对于前期免疫治疗有相对禁忌症或 PS 低于 1 的患者,可以使用适合组织学的铂类双药化疗(见上文),对于非鳞状组织学的患者,可加用或不加用贝伐珠单抗。机翻
「Fast Facts Non-Small-Cell Lung Cancer」评价该例句:好评差评指正